American heart journal · 2024
Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial.
Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iannopollo Gianmarco, Cocco Marta, Leone Alessandro, Saccà Salvatore, Mangino Domenico, Picchi Andrea, Reccia Matteo Rocco, Fineschi Massimo, Meliga Emanuele, Audo Andrea, Nobile Giampiero, Tumscitz Carlo, Penzo Carlo, Saia Francesco, Rubboli Andrea, Moretti Carolina, Vignali Luigi, Niccoli Giampaolo, Cimaglia Paolo, Rognoni Andrea, Aschieri Daniela, Iaccarino Daniele, Ottani Filippo, Cavazza Caterina, Varbella Ferdinando, Secco Gioel Gabrio, Bolognese Leonardo, Limbruno Ugo, Guiducci Vincenzo, Campo Gianluca, Casella Gianni
Аннотация
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has emerged as an effective and safe treatment for patients with symptomatic aortic stenosis. The indication to TAVI should be agreed upon by a Heart Team, and the procedure should be performed in centers with on-site cardiac surgery. However, TAVI complications requiring emergent cardiac surgery (ECS) have become very rare. Concurrently, access disparities and prolonged waiting times are pressing issues due to increasing clinical demand of TAVI. Many solutions have been proposed and one of them is the possibility of performing TAVI in centers without on-site cardiac surgery.
METHODS AND DESIGN: The Transcatheter Aortic-Valve Implantation with or without on-site Cardiac Surgery (TRACS) trial is a prospective, randomized, multicenter, open-label study with blinded adjudicated evaluation of outcomes. Patients with symptomatic severe aortic stenosis and deemed inoperable, at high surgical risk, or presenting with at least 1 clinical factor compromising the benefit/risk ratio for ECS, will be randomized to undergo TAVI either in centers with or without on-site cardiac surgery. The primary endpoint will be the composite occurrence of all-cause death, stroke, and hospital readmission for cardiovascular causes at one year. The safety endpoint will include death attributable to periprocedural complications actionable by ECS. The study aims to enroll 566 patients.
IMPLICATIONS: The TRACS trial aims to address critical gaps in knowledge regarding the safety and efficacy of TAVI procedures performed in centers without on-site cardiac surgery, potentially improving access and outcomes for high-risk patients.
TRIAL REGISTRATION: ClinicalTrials.gov NCT05751577.
METHODS AND DESIGN: The Transcatheter Aortic-Valve Implantation with or without on-site Cardiac Surgery (TRACS) trial is a prospective, randomized, multicenter, open-label study with blinded adjudicated evaluation of outcomes. Patients with symptomatic severe aortic stenosis and deemed inoperable, at high surgical risk, or presenting with at least 1 clinical factor compromising the benefit/risk ratio for ECS, will be randomized to undergo TAVI either in centers with or without on-site cardiac surgery. The primary endpoint will be the composite occurrence of all-cause death, stroke, and hospital readmission for cardiovascular causes at one year. The safety endpoint will include death attributable to periprocedural complications actionable by ECS. The study aims to enroll 566 patients.
IMPLICATIONS: The TRACS trial aims to address critical gaps in knowledge regarding the safety and efficacy of TAVI procedures performed in centers without on-site cardiac surgery, potentially improving access and outcomes for high-risk patients.
TRIAL REGISTRATION: ClinicalTrials.gov NCT05751577.